Drugs & Targets FDA grants Rubraca Priority Review for advanced prostate cancer January 17, 2020Vol.46 No.03
Drugs & Targets FDA accepts BLA for Priority Review of Opdivo + Yervoy in first-line NSCLC January 17, 2020Vol.46 No.03
Drugs & Targets Concerto HealthAI collaborates with Pfizer, Janssen; launches eurekaHealth 3.0 January 17, 2020Vol.46 No.03
Drugs & Targets Roche, Illumina collaborate to broaden patient access to genomic testing January 17, 2020Vol.46 No.03
Drugs & Targets Qiagen, Amgen collaborate on companion diagnostic development in NSCLC January 17, 2020Vol.46 No.03
Clinical Roundup Multimodal genomic analyses predict response to immunotherapy in NSCLC January 17, 2020Vol.46 No.03
Clinical Roundup Nanoparticle therapy offers potential new treatment for aggressive breast cancer January 17, 2020Vol.46 No.03
Clinical Roundup MEAL study: eating more veggies, fruits will not cure, stop prostate cancer January 17, 2020Vol.46 No.03
